Medical Research News

RSS

Carbon-based nanomaterials as potential COVID-19 treatments

An international team of researchers says that carbon-based nanomaterials (CBNs) could represent promising new approaches to treating coronavirus disease 2019 (COVID-19) pneumonia that is complicated by a secondary bacterial, viral or fungal infection.

19 Jan 2021

Aerobic fitness is not linked to motor skills, study shows

Clumsy kids can be as aerobically fit as their peers with better motor skills, a new Finnish study shows. The results are based on research conducted at the Faculty of Sport and Health Sciences of the University of Jyväskylä and the Institute of Biomedicine of the University of Eastern Finland, and they were published in Translational Sports Medicine.

19 Jan 2021

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armored immune cells that can attack recurring cancer in liver transplant patients, while temporarily evading immunosuppressant drugs patients take to avoid organ rejection.

19 Jan 2021

Data analysis reveals a second decline in cardiovascular admissions during COVID-19 pandemic

Data analysis is revealing a second sharp drop in the number of people admitted to hospital in England with acute heart failure or a heart attack.

19 Jan 2021

Wuhan study has important implications for managing COVID-19 pandemic

Researchers in China and the United States have conducted a study assessing the household transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has important implications for managing the coronavirus disease 2019 (COVID-19) pandemic.

19 Jan 2021

Effects of low-fat, plant-based diet compared to low-carb, animal-based diet

People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.

19 Jan 2021

Young people experience the highest levels of loneliness during COVID-19 lockdown

People under 30 and people with a history of mental illness experience the highest levels of loneliness and anxiety during COVID-19 lockdown.

19 Jan 2021

Olfactory loss is the best predictor of COVID-19

Two international studies confirm that for the majority of patients with respiratory infections who lose the sense of smell, this is due to COVID-19.

19 Jan 2021

Study shows high prevalence of mental health conditions among children with autism

Nearly 78 per cent of children with autism have at least one mental health condition and nearly half have two mental health conditions or more, according to a new U.S. study from the University of British Columbia's department of psychology and the AJ Drexel Autism Institute at Drexel University (Pennsylvania).

19 Jan 2021

Researchers focus on specific neurons that make reaching-and-grasping tasks possible

Research conducted at the Okinawa Institute of Science and Technology Graduate University, has looked at the importance of specific neurons for seemingly simple, day-to-day tasks that involve reaching for and grasping objects.

19 Jan 2021

Routine thoracic surgery could be performed safely during the COVID-19 pandemic

A study in the Journal of Thoracic Oncology comparing surgeries performed at one Chinese hospital in 2019 with a similar date range during the COVID-19 pandemic found that routine thoracic surgery and invasive examinations were performed safely.

19 Jan 2021

Study finds sex differences in the effects of prenatal BPA exposure on autism-related genes

A new study by researchers from Chulalongkorn University, Tohoku University, and The George Washington University is the first to identify autism candidate genes that may be responsible for the sex-specific effects of bisphenol A (BPA) on the brain.

19 Jan 2021

Memory B cell response to SARS-CoV-2 evolves up to 6 months after infection, study finds

A new study shows that the memory B cell response to SARS-Cov-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence.

19 Jan 2021

Which SARS-CoV-2 mutations can potentially evade antibody recognition?

A team of US-based researchers has systematically identified SARS-CoV-2 mutations that could potentially evade neutralizing antibodies produced by the current vaccine candidates.

19 Jan 2021

Study predicts good passive immunotherapy donors to combat COVID-19

A US-based research team determine good candidates for convalescent plasma donations in promoting passive immunity among severely-ill COVID-19 patients.

19 Jan 2021

Researchers receive $460,000 NIH grant for brain imaging study

Michael Alosco, PhD, associate professor of neurology at Boston University School of Medicine, and Gil Rabinovici, MD, professor of neurology and radiology at the University of California San Francisco have been awarded a two-year, $460,000 grant from the National Institute of Neurological Disorders and Stroke, which is part of the National Institutes of Health.

19 Jan 2021

A common genetic variant identified as risk factor for stroke

A team of Geisinger researchers has identified a common genetic variant as a risk factor for stroke, especially in patients older than 65.

19 Jan 2021

New coronavirus strain found in more than one-third of COVID-19 cases in Los Angeles

A new strain of the coronavirus has been found in more than one-third of COVID-19 cases in Los Angeles and may be contributing to the acceleration of the recent surge of cases across Southern California, according to new research from Cedars-Sinai.

19 Jan 2021

RECoVERY: New open-source software developed for analyzing SARS-CoV-2 genomes

Researchers report an open-source platform-independent tool for building SARS-CoV-2 genomes from raw sequencing reads. The tool can be used without any extra hardware or software and be run using any browser from a desktop or mobile.

19 Jan 2021

Kruppel-like factor 2 may be a major determinant of acute respiratory distress syndrome in COVID-19 patients

A study conducted at the University of Chicago, USA, has recently revealed that downregulation of an endothelial transcription factor, Kruppel-like factor 2, by SARS-CoV-2 is responsible for ARDS frequently observed in critically ill COVID-19 patients.

19 Jan 2021

Medical Research News

Carbon-based nanomaterials as potential COVID-19 treatments

Aerobic fitness is not linked to motor skills, study shows

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Data analysis reveals a second decline in cardiovascular admissions during COVID-19 pandemic

Wuhan study has important implications for managing COVID-19 pandemic

Effects of low-fat, plant-based diet compared to low-carb, animal-based diet

Young people experience the highest levels of loneliness during COVID-19 lockdown

Olfactory loss is the best predictor of COVID-19

Study shows high prevalence of mental health conditions among children with autism

Researchers focus on specific neurons that make reaching-and-grasping tasks possible

Routine thoracic surgery could be performed safely during the COVID-19 pandemic

Study finds sex differences in the effects of prenatal BPA exposure on autism-related genes

Memory B cell response to SARS-CoV-2 evolves up to 6 months after infection, study finds

Which SARS-CoV-2 mutations can potentially evade antibody recognition?

Study predicts good passive immunotherapy donors to combat COVID-19

Researchers receive $460,000 NIH grant for brain imaging study

A common genetic variant identified as risk factor for stroke

New coronavirus strain found in more than one-third of COVID-19 cases in Los Angeles

RECoVERY: New open-source software developed for analyzing SARS-CoV-2 genomes

Kruppel-like factor 2 may be a major determinant of acute respiratory distress syndrome in COVID-19 patients

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News